Joel A. Fernandes
Keine laufenden Positionen mehr
Karriereverlauf von Joel A. Fernandes
Ehemalige bekannte Positionen von Joel A. Fernandes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INNOVIVA, INC. | Corporate Officer/Principal | 01.01.2005 | 01.03.2006 |
| KLA CORPORATION | Corporate Officer/Principal | 01.08.2002 | 01.01.2005 |
| ALZA CORPORATION | Corporate Officer/Principal | 01.01.1999 | 01.01.2002 |
| INNOVIVA, INC. | Corporate Officer/Principal | - | - |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Comptroller/Controller/Auditor | 01.04.2006 | - |
| Finanzdirektor/CFO | 01.04.2006 | - | |
| Investor Relations Kontakt | 01.04.2006 | 02.12.2013 | |
| Public Communications Contact | 01.04.2006 | 02.12.2013 |
Ausbildung von Joel A. Fernandes
| Manchester College | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 4 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| KLA CORPORATION | Electronic Technology |
| Private Unternehmen | 2 |
|---|---|
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
- Börse
- Insiders
- Joel A. Fernandes
- Erfahrung
